(Q33360073)
Statements
1 reference
A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers (English)
1 reference
M J MacKenzie
1 reference
H W Hirte
1 reference
L L Siu
1 reference
K Gelmon
1 reference
M Ptaszynski
1 reference
B Fisher
1 reference
E Eisenhauer
1 reference
1 April 2004
1 reference
1 reference
15
1 reference
665-670
1 reference
Identifiers
1 reference
1 reference